|
Volumn 34, Issue 12, 2015, Pages 1630-1633
|
Who wants a left ventricular assist device for ambulatory heart failure? Early insights from the MEDAMACS screening pilot
a b c d e f g h h i j a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BRAIN NATRIURETIC PEPTIDE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ASSISTED CIRCULATION;
CARDIAC RESYNCHRONIZATION THERAPY;
CARDIOVASCULAR MORTALITY;
EXERCISE TEST;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART SURGERY;
HEART TRANSPLANTATION;
HUMAN;
LEFT VENTRICULAR ASSIST DEVICE;
LETTER;
LIFE EXPECTANCY;
OXYGEN CONSUMPTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SODIUM BLOOD LEVEL;
SURVIVAL;
VISUAL ANALOG SCALE;
AGED;
CROSS-SECTIONAL STUDY;
FEMALE;
HEART ASSIST DEVICE;
MALE;
MIDDLE AGED;
QUESTIONNAIRE;
AGED;
CROSS-SECTIONAL STUDIES;
FEMALE;
HEART FAILURE;
HEART-ASSIST DEVICES;
HUMANS;
MALE;
MIDDLE AGED;
SURVEYS AND QUESTIONNAIRES;
|
EID: 84951574316
PISSN: 10532498
EISSN: 15573117
Source Type: Journal
DOI: 10.1016/j.healun.2015.07.009 Document Type: Letter |
Times cited : (20)
|
References (7)
|